Paid Clinical Trials Colorado Springs

Discover 366 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 366

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Littleton CO, Albuquerque NM, Rapid City SD, Sandy UTshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Littleton CO, Aurora CO, Farmington NM, Albuquerque NMshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Rexlemestrocel-L & HAEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Recruiting

PHASE3

Sponsor:

Mesoblast, Ltd.

Location:

Greenwood CO, Edmond OK, Kansas City KS, Boise IDshow 18 more

Code:

NCT06325566

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rexlemestrocel-L + HA mixture

Saline

VafseoVafseo Outcomes In-Center Experience

Recruiting

PHASE3

Sponsor:

USRC Kidney Research

Location:

Lone Tree CO, Gallup NM, Dallas TX, Live Oak TXshow 1 more

Code:

NCT06520826

Conditions

Anemia of Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vadadustat

Erythropoiesis Stimulating Agent

MilvexianA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Littleton CO, Amarillo TX, Rapid City SD, Lincoln NEshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

PXL-Platinum 330Safety and Effectiveness of the PXL-Platinum 330 System

Recruiting

PHASE1

PHASE2

Sponsor:

Colorado Eye Consultants/Cornea Consultants of Colorado

Location:

Littleton CO, Highland Park IL, Brecksville OH

Code:

NCT04401865

Conditions

Corneal Ectasia

Keratoconus

Pellucid Marginal Corneal Degeneration

Eligibility Criteria

Sex: All

Age: 8+

Healthy Volunteers: Not accepted

Interventions

PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

Observational StudyThe PREDICT Registry:

Recruiting

Sponsor:

PreludeDx

Location:

Colorado Springs CO, Aurora CO, Phoenix AZ, Houston TXshow 11 more

Code:

NCT03448926

Conditions

DCIS

Eligibility Criteria

Sex: Female

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Treatment Recommendation Surveys

7-gene biosignature

BDA with HFOA Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Englewood CO, Wheat Ridge CO, West Jordan UT, Omaha NEshow 62 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

NTLA-2002HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Recruiting

PHASE3

Sponsor:

Intellia Therapeutics

Location:

Colorado Springs CO, Centennial CO, Scottsdale AZ, Dallas TXshow 12 more

Code:

NCT06634420

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

NTLA-2002

Normal Saline IV Administration

BupropionBupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Lone Tree CO, Denver CO, Lafayette CO, Garden City KSshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration